Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
β-Estradiol 17-valerate is a synthetic estrogen.1,2,3 It increases estrogen receptor β (ERβ), but not ERα, levels in the hippocampus and cortex of ovariectomized rats when administered at a dose of 0.3 mg/day.1 Intradermal administration of β-estradiol 17-valerate (5 µg/animal) induces transient permanent diestrus and decreases litter size in rats.2 β-Estradiol 17-valerate has been used to induce polycystic ovarian syndrome in rats.3 It has been found in wastewater effluent.4 Formulations containing β-estradiol 17-valerate have been used in hormone replacement therapy and in the treatment of menopausal symptoms, as well as in oral contraceptives in combination with dienogest.
WARNING This product is not for human or veterinary use.
1. Two estrogen replacement therapies differentially regulate expression of estrogen receptors alpha and beta in the hippocampus and cortex of ovariectomized rat. Brain Res. Mol. Brain Res. 142(2), 107-114 (2005).
2. Estradiol valerate as a possible endocrine reproductive disruptor: Evidence from an in vivo rat model. Fertil. Steril. 91(4 Suppl), 1510-1512 (2009).
3. Evaluation of glycemic and oxidative/antioxidative status in the estradiol valerate-
4. Occurrences of six steroid estrogens from different effluents in Beijing, China. Environ. Monit. Assess. 184(3), 1719-1729 (2012).